Mission
The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma.
Public Charity
Scleroderma Research Foundation
Scleroderma Research Foundation, of San Francisco, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $13.1M in revenue, $10.3M in expenses, $42.2M in total assets. 98 publicly reported grants to this organization, totaling roughly $5.1M, appear in IRS filings.
EIN: 680087234
San Francisco, CA
Medical Research
NTEE: H
Latest filing: 2025
Total Revenue$13.1M
Total Expenses$10.3M
Total Assets$42.2M
Grant Records98
Funding Total$5.1M
Filing Years2021–2025
Where $100 goes at Scleroderma Research Foundation
How Scleroderma Research Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$86
Programs
the work itself
$6
Management
running the organization
$8
Fundraising
raising the next dollar
Inside the $86 for programs
$38
CONQUEST is a global, perpetual, clinical trial platform developed by the SRF in coordination with partner biopharmaceutical companies to accelerate the clinical development of agents for scleroderma
$37
The mission of the Scleroderma Research Foundation (SRF) is to find, fund, and facilitate the most promising, highest-quality research to cure scleroderma
$6
SRF Education & Awareness Program
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$50,000
For grant recipient's exempt purposes
$670,030
FOR GENERAL AND PROJECT SUPPORT
$111,000
PROGRAMATIC SUPPORT
$77,000
PROGRAMATIC SUPPORT
$77,000
Showing up to 5 of 98 total records — full history available with membership.
Officers & Directors
Dir. Philanthropy
Anoushka Donnelley
Board Member
Dan Schimberg
Board Member
David Knoller
Treasurer
Deann Wright
Board Member
Eric Kau Md
VP Communications
Gloria Blecha
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $13.1M | $10.3M | $42.2M |
| 2024 | $12.2M | $9.6M | $33.0M |
| 2023 | $8.4M | $6.5M | $18.7M |
| 2022 | $5.9M | $4.7M | $11.1M |
| 2021 | $3.8M | $3.7M | $9.8M |
Between 2021 and 2025, reported annual revenue grew from $3.8M to $13.1M (+248%), with total assets most recently reported at $42.2M.
Interactive year-over-year charts and full filing details available with membership.